Oral Micronized Progesterone Cost in Illinois 2026

What Does Oral Micronized Progesterone Actually Cost in Illinois?

Oral micronized progesterone (OMP) is available to Illinois residents at several distinct price points depending on whether they pay cash, use insurance, or access a compounding pharmacy. The manufacturer list price for brand-name Prometrium sits at $180 for a 30-day supply. Most Illinois patients who pay out of pocket will not pay that figure. Across Illinois retail chains, Walgreens, CVS, Jewel-Osco Pharmacy, and Costco, the average cash-pay price in 2026 runs approximately $45 per month for a generic 100 mg or 200 mg supply.

Brand vs. Generic Price Difference

Prometrium (manufactured by Besins Healthcare, distributed through AbbVie) carries the highest sticker price. Generic oral micronized progesterone capsules, approved by the FDA under the same bioequivalence standards, bring the retail cost down substantially. The FDA's Orange Book lists multiple approved generic manufacturers [1]. Choosing a generic over the brand at a Chicago or Peoria pharmacy alone may cut the monthly bill by 60 to 70 percent before any coupon is applied.

Compounded Progesterone Pricing

Patients who obtain a prescription filled at a licensed Illinois 503A compounding pharmacy may pay approximately $25 per month. That figure reflects typical compounding overhead for progesterone capsules prepared to a specific patient prescription. Compounded progesterone is not FDA-approved as a finished drug product; the FDA has issued guidance distinguishing 503A patient-specific compounding from mass production [2]. The lower price point makes compounding attractive for patients who need non-standard doses or who cannot tolerate the peanut-oil base used in Prometrium capsules.

GoodRx and Discount Programs

GoodRx coupons applied to generic oral micronized progesterone at Illinois pharmacies can bring the 30-day price to $15 to $35 depending on the dispensing pharmacy and the exact NDC. Blink Health and RxSaver offer comparable discounts. These programs do not constitute insurance and cannot be used simultaneously with Medicaid or Medicare Part D.

Illinois Medicaid Coverage for Oral Micronized Progesterone

Illinois Medicaid (Medicaid Managed Care through the Illinois Department of Healthcare and Family Services) covers oral micronized progesterone for endometrial protection in postmenopausal women receiving estrogen therapy, but a prior authorization (PA) is required [3]. The PA pathway exists because OMP is a higher-cost hormonal agent relative to medroxyprogesterone acetate (MPA), the synthetic progestin that appeared on earlier Medicaid preferred drug lists.

Prior Authorization Requirements

To obtain PA approval through Illinois Medicaid managed care plans (Meridian Health Plan of Illinois, Molina Healthcare of Illinois, IlliniCare, and others), a prescriber typically must document:

• The patient's diagnosis (e.g., menopausal status with intact uterus)
• The concurrent estrogen prescription that necessitates progestogen protection
• A clinical reason for OMP over a preferred synthetic progestin (e.g., MPA intolerance or contraindication)

The PEPI Trial (N=875, published in JAMA 1995) remains the foundational evidence that OMP produces a more favorable endometrial and lipid profile than MPA when combined with conjugated equine estrogen, which supports the clinical rationale for PA documentation [4]. The trial showed that the group receiving CEE plus cyclic micronized progesterone had endometrial hyperplasia rates statistically indistinguishable from placebo, while CEE alone produced hyperplasia in 62 percent of participants over three years [4].

Illinois Medicaid Managed Care Plan Formularies

Formulary placement varies by managed care organization. Patients covered under the Illinois Medicaid fee-for-service (FFS) program should check the HFS Preferred Drug List directly, as the FFS list is updated quarterly and OMP tier placement may shift. Patients in managed care should call the plan's pharmacy benefit line or ask the prescriber to run a formulary check before submitting the PA.

Is Compounded Progesterone Legal in Illinois?

Compounded oral progesterone prepared by a licensed 503A pharmacy is legal in Illinois, provided the pharmacy holds an active Illinois Department of Financial and Professional Regulation (IDFPR) pharmacy license and operates under the federal Drug Quality and Security Act (DQSA) 503A framework [5]. The 503A framework requires that compounded preparations be made pursuant to a valid patient-specific prescription from a licensed prescriber, using USP-grade active pharmaceutical ingredients, and not as commercial-scale copies of FDA-approved drugs.

503A vs. 503B: The Illinois Distinction

Illinois residents should understand the difference between 503A and 503B facilities. A 503A pharmacy compounds for individual patients under a prescription. A 503B outsourcing facility may produce larger batches for office use but operates under FDA oversight similar to a drug manufacturer [6]. Oral micronized progesterone for individual patients in Illinois is most commonly dispensed from 503A compounding pharmacies. Buying bulk compounded hormone products from an unregistered online pharmacy violates both federal law and Illinois pharmacy statutes [7].

Peanut Oil Allergy Consideration

Prometrium capsules contain peanut oil as an excipient. The FDA label carries a warning for patients with peanut allergy [8]. A compounding pharmacy can prepare oral progesterone in an alternative oil base (e.g., olive oil or sesame oil) under a physician's written direction, which is one clinically valid reason to choose a compounded formulation over the commercial product.

Which Insurance Plans Cover Oral Micronized Progesterone in Illinois?

Most commercial insurance plans available through the Illinois health insurance exchange (Get Covered Illinois) and employer-sponsored plans cover oral micronized progesterone, though tier placement varies widely [9]. Patients on a Tier 1 or Tier 2 formulary plan may pay $10 to $40 per month in copays. Those whose plan places generic OMP on Tier 3 or higher may face $60 to $120 per month in cost sharing before deductible.

ACA Exchange Plans (Marketplace Coverage)

Under the Affordable Care Act, prescription contraceptives are covered without cost sharing, but OMP prescribed for menopausal hormone therapy (not contraception) does not automatically trigger the zero-cost-sharing rule. Illinois marketplace enrollees should review the Summary of Benefits and Coverage (SBC) for their specific plan or call the plan's member services line. BCBS of Illinois, Cigna, and Aetna all offer individual plans on the Illinois exchange with varying OMP tier placements.

Medicare Part D Coverage

Medicare Part D plans available in Illinois generally cover generic oral micronized progesterone on Tier 2 or Tier 3. The 2026 Medicare Part D out-of-pocket cap of $2,000 per year (a change under the Inflation Reduction Act) means catastrophic cost exposure for OMP alone is unlikely, as annual OMP costs rarely exceed $540 even at retail price [10]. Patients in the coverage gap should ask the prescriber to submit a coverage exception if MPA is contraindicated.

Employer-Sponsored Plans

Large Illinois employers (those with 50 or more full-time employees) subject to ACA employer mandate rules typically include generic OMP on their pharmacy formularies. Employees at companies with self-insured plans should contact the plan administrator or Human Resources to request the formulary tier for progesterone (oral capsule) before filling the prescription.

How to Get the Cheapest Price on Oral Micronized Progesterone in Illinois

The lowest accessible price depends on the patient's insurance status and pharmacy choice. A structured comparison of options available in Illinois in 2026 follows.

Step 1: Check Generic Availability First

Always ask the pharmacy to dispense the generic (progesterone capsules, USP, micronized). The FDA bioequivalence standard for oral micronized progesterone requires the generic to match the brand's rate and extent of absorption within an accepted confidence interval [11]. Pharmacologically, approved generics perform the same endometrial-protective function documented in the PEPI Trial [4].

Step 2: Apply a Coupon or Discount Card

GoodRx, RxSaver, and NeedyMeds coupons reduce the cash price at most Illinois pharmacies. Costco Pharmacy in Chicago, Schaumburg, or Bloomington Normal regularly offers among the lowest baseline cash prices for generic OMP in the state, sometimes below $20 per month without any coupon. Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists generic progesterone 100 mg capsules at a transparent cost-plus-15-percent price; Illinois patients with a valid prescription can order directly for mail delivery.

Step 3: Evaluate 503A Compounding

If cost remains a barrier after coupons, a licensed compounding pharmacy may offer 100 mg or 200 mg oral progesterone capsules for around $25 per month. The prescriber must write the prescription specifying the dose, base oil, capsule count, and directions. The Illinois Pharmacists Association maintains a directory of licensed Illinois compounding pharmacies [12].

Step 4: Apply for Patient Assistance

AbbVie's patient assistance program (myAbbVie Assist) covers Prometrium brand for qualifying patients who lack prescription drug coverage and meet income thresholds. Applications are available at abbvie.com/patients or by calling the AbbVie patient support line. Illinois residents whose household income falls at or below 400 percent of the federal poverty level may qualify.

Step 5: Request a 90-Day Supply

Many Illinois retail pharmacies and mail-order pharmacy benefit managers (PBMs) charge lower per-unit costs for 90-day supplies compared to monthly fills. A 90-day supply of generic OMP at a warehouse club pharmacy in Illinois may cost $40 to $50 total, roughly the same as a single 30-day retail fill at a chain pharmacy without a coupon.

Telehealth Prescribing of Oral Micronized Progesterone in Illinois

Illinois law permits telehealth prescribing of oral micronized progesterone. The Illinois Department of Public Health and the Illinois Medical Practice Act allow licensed physicians, advanced practice registered nurses (APRNs), and physician assistants to prescribe Schedule-non-controlled prescription drugs via synchronous audio-visual telehealth encounters without a prior in-person visit, provided the prescriber can adequately assess the patient [13].

Telehealth-Specific Considerations

OMP is not a controlled substance under the DEA Controlled Substances Act or the Illinois Controlled Substances Act, which means prescribing it via telehealth does not trigger the stricter Ryan Haight Act telemedicine rules that apply to buprenorphine or testosterone [14]. A prescriber conducting a telehealth menopause consultation may order a pelvic or breast history, review prior labs, and issue an OMP prescription entirely remotely.

What the Prescriber Must Confirm Before Prescribing

• Intact uterus (to confirm need for progestogen)
• Current estrogen type and dose
• No contraindications (personal history of breast cancer, active DVT, liver disease, peanut allergy if prescribing Prometrium brand)
• Baseline endometrial status if symptomatic bleeding is present

The Endocrine Society's 2022 clinical practice guideline on menopause hormone therapy states: "Micronized progesterone is preferred over synthetic progestins for endometrial protection because of its more favorable cardiovascular and breast safety profile in observational data." [15] That preference supports the clinical rationale for OMP prescribing in a telehealth setting.

Clinical Background: Why OMP Is Prescribed

Understanding the pharmacology helps patients advocate for themselves with insurers.

Mechanism and Endometrial Protection

Oral micronized progesterone binds the progesterone receptor in endometrial tissue, opposing the proliferative effect of estrogen. Without adequate progestogen opposition, postmenopausal women with an intact uterus who take systemic estrogen face a substantially elevated risk of endometrial hyperplasia and endometrial cancer. The FDA label for Prometrium specifies its use for endometrial protection as a secondary prevention measure in this population [8].

PEPI Trial Evidence

The PEPI Trial randomized 875 women over three years across five treatment arms. The arm receiving conjugated equine estrogen 0.625 mg plus cyclic micronized progesterone 200 mg for 12 days per month showed endometrial hyperplasia rates of 1 to 2 percent, matching placebo and outperforming CEE plus MPA [4]. The trial also showed that OMP, unlike MPA, did not blunt the HDL-raising effect of estrogen. That lipid-friendly profile was later cited in the 2002 WHI analyses comparing estrogen-progestin combinations [16].

Dosing Regimens Used in Illinois Practice

Illinois prescribers most commonly order OMP in one of two patterns:

• Continuous combined: 100 mg nightly with continuous estrogen, commonly used in postmenopausal women more than one year past last menses
• Cyclic sequential: 200 mg nightly for 12 to 14 days per calendar month, used in perimenopausal women or those who prefer withdrawal bleeding

The FDA-approved dosing for endometrial protection is 200 mg orally at bedtime for 12 days per 28-day cycle [8]. Off-label continuous use at 100 mg nightly is widely practiced and supported by the North American Menopause Society (NAMS) 2022 position statement [17].

Illinois-Specific Savings Card and Discount Program Details

AbbVie/Prometrium Savings Card

AbbVie offers a copay savings card for commercially insured patients that may reduce the out-of-pocket cost of brand Prometrium to as low as $0 per month, subject to a maximum annual benefit cap. Illinois patients must verify eligibility each calendar year. The savings card is not valid for patients enrolled in Medicaid, Medicare, or any other federal health care program [18].

NeedyMeds and RxAssist

NeedyMeds (needymeds.org) maintains an updated database of patient assistance programs for progesterone products accessible to Illinois residents. RxAssist lists both manufacturer and state pharmaceutical assistance programs. Neither site requires a subscription, and both provide direct links to program applications.

Illinois SeniorCare and Circuit Breaker Programs

Illinois residents aged 65 or older who do not qualify for Medicare Part D low-income subsidy (LIS/Extra Help) may access the Illinois SeniorCare pharmaceutical assistance program. SeniorCare provides a co-payment benefit for covered prescription drugs, and progesterone oral capsules fall within the program's covered drug categories. Eligibility is income-based; the current income threshold is published annually by the Illinois Department on Aging [19].

Key Safety and Drug Interaction Points for Illinois Telehealth Patients

Prescribers and patients should be aware of interactions relevant to OMP before the first fill.

CYP2C19 and CYP3A4 Interactions

Oral micronized progesterone is metabolized primarily by CYP2C19 and CYP3A4 hepatic enzymes. Strong CYP3A4 inducers (rifampin, carbamazepine, St. John's Wort) may reduce OMP plasma concentrations. Strong CYP3A4 inhibitors (ketoconazole, ritonavir) may increase OMP exposure. Illinois patients on antiretroviral therapy for HIV should alert their prescriber; drug-drug interaction modeling may change the dose or timing [20].

Sedation

OMP taken at bedtime produces a mild sedating effect due to conversion to allopregnanolone, a GABA-A receptor positive modulator. Patients should avoid driving or operating heavy machinery within four hours of the dose. This property is sometimes used therapeutically for women with menopausal sleep disruption, as documented in the literature on OMP's sleep-promoting effects [21].

Contraindications

The FDA label lists the following absolute contraindications: known sensitivity to progesterone or peanut oil, undiagnosed abnormal genital bleeding, known or suspected malignancy of the breast or genital organs, active DVT or pulmonary embolism, active arterial thromboembolic disease, and liver dysfunction or disease [8].